or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    INDP D Indaptus Therapeutics, Inc. -0.43
    EVAX F Evaxion Biotech A/S -3.00
    RENB F Renovaro Biosciences Inc. 0.88
    MRNA F Moderna, Inc. 0.50
    AGEN F Agenus Inc. -3.57
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy Coronavirus

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 3.14
    FBT A First Trust Amex Biotech Index Fund 3.09
    LGHT D Langar Global HealthTech ETF 2.38
    IBBQ D Invesco Nasdaq Biotechnology ETF 2.05
    XBI B SPDR S&P Biotech ETF 2.02
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare BBH to FBT Compare BBH to LGHT Compare FBT to IBBQ

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        Oct 31 MRNA Moderna (MRNA) Stock Moves -0.66%: What You Should Know
        Oct 31 MRNA These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election?
        Oct 31 MRNA Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines
        Oct 31 MRNA Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?
        Oct 31 MRNA Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
        Oct 31 EVAX Evaxion Biotech ADS GAAP EPS of -$0.04, revenue of $3.01M
        Oct 31 EVAX Evaxion announces business update and third quarter 2024 financial results
        Oct 31 MRNA Moderna to Present at Upcoming Conferences in November 2024
        Oct 31 EVAX EVAX Exceeds Estimates and Confirms Partnership
        Oct 30 RENB Renovaro files for $200M mixed securities shelf
        Oct 30 MRNA Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?
        Oct 29 MRNA Moderna (MRNA) Exceeds Market Returns: Some Facts to Consider
        Oct 29 MRNA Moderna price target lowered to $60 from $105 at Evercore ISI
        Oct 29 MRNA Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer
        Oct 28 MRNA Moderna’s Stock-Price Target Slashed. It’s About Vaccines.
        Oct 28 EVAX Evaxion to announce business update and third quarter 2024 financial results on October 31
        Oct 28 MRNA Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
        Oct 26 MRNA Who Should Get Covid and Flu Vaccines This Year—and the Best Time to Get Them
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy Coronavirus
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags